Chubb Limited

BRSE:004432874 Stock Report

Market Cap: CHF 102.8b

Chubb Valuation

Is 004432874 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 004432874 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 004432874 (CHF250) is trading below our estimate of fair value (CHF595.56)

Significantly Below Fair Value: 004432874 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 004432874?

Key metric: As 004432874 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 004432874. This is calculated by dividing 004432874's market cap by their current earnings.
What is 004432874's PE Ratio?
PE Ratio11.6x
EarningsUS$10.00b
Market CapUS$116.39b

Price to Earnings Ratio vs Peers

How does 004432874's PE Ratio compare to its peers?

The above table shows the PE ratio for 004432874 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.2x
ZURN Zurich Insurance Group
17.7x1.6%CHF 76.7b
SREN Swiss Re
13.9x12.6%CHF 36.3b
SLHN Swiss Life Holding
18.7x2.5%CHF 20.2b
PGR Progressive
18.6x-0.09%US$149.8b
004432874 Chubb
11.6x1.0%CHF 116.4b

Price-To-Earnings vs Peers: 004432874 is good value based on its Price-To-Earnings Ratio (11.6x) compared to the peer average (17.2x).

Price to Earnings Ratio vs Industry

How does 004432874's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
004432874 11.6xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 004432874 is good value based on its Price-To-Earnings Ratio (11.6x) compared to the European Insurance industry average (11.8x).

Price to Earnings Ratio vs Fair Ratio

What is 004432874's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

004432874 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 004432874's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 004432874 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 250.00
CHF 263.63
+5.5%
8.2%CHF 307.82CHF 216.09n/a21
Nov ’25CHF 242.65
CHF 257.07
+5.9%
8.3%CHF 301.35CHF 211.55n/a21
Oct ’25CHF 244.09
CHF 239.79
-1.8%
8.5%CHF 295.76CHF 200.00n/a22
Sep ’25CHF 240.27
CHF 239.69
-0.2%
6.4%CHF 263.11CHF 203.59n/a21
Aug ’25CHF 244.61
CHF 244.35
-0.1%
6.7%CHF 269.60CHF 208.61n/a21
Jul ’25CHF 231.55
CHF 241.28
+4.2%
5.5%CHF 271.82CHF 210.33n/a22
Jun ’25CHF 243.24
CHF 246.19
+1.2%
5.0%CHF 268.57CHF 215.59n/a22
May ’25n/a
CHF 245.09
0%
6.3%CHF 272.98CHF 207.73n/a23
Apr ’25n/a
CHF 230.77
0%
7.2%CHF 251.82CHF 199.69n/a23
Mar ’25n/a
CHF 228.07
0%
7.3%CHF 250.84CHF 198.91n/a23
Feb ’25CHF 212.79
CHF 217.63
+2.3%
7.6%CHF 244.45CHF 188.70n/a23
Jan ’25n/a
CHF 205.34
0%
7.4%CHF 231.73CHF 171.06n/a22
Dec ’24CHF 203.91
CHF 212.71
+4.3%
7.7%CHF 240.81CHF 176.48n/a22
Nov ’24n/a
CHF 221.68
0%
7.6%CHF 251.47CHF 184.29CHF 242.6521
Oct ’24n/a
CHF 209.55
0%
8.6%CHF 237.18CHF 168.66CHF 244.0920
Sep ’24CHF 173.83
CHF 209.55
+20.5%
8.6%CHF 237.18CHF 168.66CHF 240.2720
Aug ’24n/a
CHF 208.57
0%
8.5%CHF 236.32CHF 168.05CHF 244.6120
Jul ’24n/a
CHF 212.97
0%
8.9%CHF 242.50CHF 172.44CHF 231.5520
Jun ’24n/a
CHF 218.16
0%
7.9%CHF 245.94CHF 175.80CHF 243.2419
May ’24n/a
CHF 215.76
0%
7.7%CHF 241.32CHF 172.50n/a20
Apr ’24n/a
CHF 222.11
0%
8.4%CHF 246.99CHF 169.23n/a20
Mar ’24n/a
CHF 224.42
0%
7.3%CHF 248.64CHF 188.78n/a20
Feb ’24n/a
CHF 222.69
0%
7.2%CHF 245.36CHF 186.29CHF 212.7920
Jan ’24n/a
CHF 217.89
0%
9.4%CHF 249.40CHF 161.65n/a18
Dec ’23n/a
CHF 218.03
0%
8.9%CHF 253.00CHF 163.98CHF 203.9119
Nov ’23n/a
CHF 231.33
0%
9.2%CHF 270.04CHF 175.02n/a20

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Vaudoise Assurances Holding

CHF 1.3b

Provides insurance products and services primarily in Switzerland.

VAHN

CHF 462.00

7D

-0.2%

1Y

9.2%

Hannover Rück

€28.9b

Provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally.

HNR1

€159.00

7D

0%

1Y

0%

NN Group

€12.6b

A financial services company, provides life and non-life insurance products in the Netherlands and internationally.

2NN

€43.75

7D

0%

1Y

n/a